Search

Your search keyword '"Babuty, A."' showing total 358 results

Search Constraints

Start Over You searched for: Author "Babuty, A." Remove constraint Author: "Babuty, A." Topic business Remove constraint Topic: business
358 results on '"Babuty, A."'

Search Results

1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

2. Platelet features allow to differentiate immune thrombocytopenia from inherited thrombocytopenia

3. Mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention

4. Platelet immunophenotyping in health and inherited bleeding disorders, a review and practical hints

5. Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions

6. Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation

7. Outcomes associated with pacemaker implantation following transcatheter aortic valve replacement: A nationwide cohort study

8. Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation

9. Single-chamber transvenous and subcutaneous defibrillators: clinical outcomes

10. Conventional transvenous or leadless ventricular permanent pacemakers: post-operative complications and mid-term follow-up

11. All-cause mortality and cardiovascular death in 52091 patients with hypertrophic cardiomyopathy. A nationwide cohort study

12. Benefits for clinical outcomes associated with dual-chamber pacing versus ventricular pacing in patients with sinus-node dysfunction: a nationwide matched control study

13. Long-term clinical outcomes in patients after catheter ablation for atrial fibrillation or atrioventricular node ablation: a French nationwide cohort study

14. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

15. Leadless pacemakers in critically ill patients requiring prolonged cardiac pacing: A multicenter international study

16. Stimulation of P2Y11 receptor protects human cardiomyocytes against Hypoxia/Reoxygenation injury and involves PKCε signaling pathway

17. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

18. Acute Dental Periapical Abscess and New-Onset Atrial Fibrillation:A Nationwide, Population-Based Cohort Study

19. Clinical outcomes with ventricular pacing or dual-chamber pacing for sinus-node dysfunction: a nationwide matched control study

20. Leadless or conventional transvenous ventricular permanent pacemakers: a nationwide matched control study

21. Subcutaneous and single-chamber transvenous defibrillators: a nationwide matched control study

22. The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy

23. The IC-D score for predicting prophylactic cardioverter-defibrillator implantation following acute myocardial infarction

24. Timing of Coronary Revascularization and Transcatheter Aortic Valve Replacement

25. Left bundle area pacing, an elegant alternative in failed cardiac resynchronization therapy implantation: A case report

26. Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study

27. Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis

28. Outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement

29. GENECHOC study: genetic markers of arrhythmic risk in heart failure

30. Impact of the timing of coronary revascularization relative to the transcatheter aortic valve implantation procedure: insights from a propensity score analysis based on a nationwide analysis

31. Development of a claims-based EuroSCORE II in patients with aortic stenosis needing surgical or transcatheter aortic valve replacement using electronic hospital records: a nationwide study

32. Outcomes in patients with acute myocardial infarction and a history of illicit drug use: a nationwide analysis

33. Relationship of aging and incident comorbidities to stroke risk in 594,169 Patients with atrial fibrillation: a nationwide analysis

34. Risk of ischemic stroke in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis

35. Bleeding risks with frailty and multimorbidity in patients with atrial fibrillation. A nationwide analysis of 1.4 million subjects

36. Leadless cardiac pacemaker implantation in patient with active tricuspid endocarditis

37. Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement

38. Flow cytometry for platelets, EDTA or not EDTA: what is the answer?

39. Futility Risk Model for Predicting Outcome After Transcatheter Aortic Valve Implantation

40. Management of previously untreated patients with severe haemophilia A preferentially treated with recombinant factor VIII products: Two French centres' real‐life experience

41. Hypercontractile esophagus resolved after radiofrequency catheter ablation for atrial fibrillation: About a case

42. Prognosis of Type 2 Myocardial Infarction Patients Implanted With a Prophylactic Defibrillator (from the Very-High-Rate Registry)

43. Number of electrocardiogram leads in the diagnosis of spontaneous Brugada syndrome

44. Early mortality after implantable cardioverter defibrillator: Incidence and associated factors

45. Pacemaker Implantation After Balloon-or Self-Expandable Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis

46. Distal‐to‐proximal delay for ablation of premature ventricular contractions

47. Clinical impact of an additional left ventricular lead in cardiac resynchronization therapy nonresponders: The V3 trial

48. Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation

49. Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort

50. A new case of heterozygous variant of the <scp>GP</scp> 1 <scp>BB</scp> gene responsible for macrothrombocytopenia

Catalog

Books, media, physical & digital resources